US Transgenic Animals Market Research Report By Products (Gene Gun, Microinjection) - Forecast to 2035

US Transgenic Animals Market Overview

As per MRFR analysis, the US Transgenic Animals Market Size was estimated at 0.88 (USD Billion) in 2023. The US Transgenic Animals Market Industry is expected to grow from 1.08(USD Billion) in 2024 to 3.14 (USD Billion) by 2035. The US Transgenic Animals Market CAGR (growth rate) is expected to be around 10.189% during the forecast period (2025 - 2035).

Key US Transgenic Animals Market Trends Highlighted

The US Transgenic Animals Market is witnessing significant trends driven by advancements in genetic engineering technologies and growing interest in genetically modified organisms (GMOs). Key market drivers include the increasing demand for improved livestock with enhanced traits such as disease resistance, faster growth rates, and better feed conversion efficiency. Regulatory support from the US government, particularly the USDA’s biotechnology regulatory framework, encourages innovation while ensuring animal and food safety. Opportunities lie in biotechnology research for developing transgenic animals that can contribute to food security and sustainability.

For instance, transgenic fish are being explored for aquaculture, presenting a viable alternative for addressing fish shortages. Additionally, as the world faces challenges related to climate change, farmers are looking for stress-resistant animals, opening doors for researchers and companies to invent transgenic solutions that can adapt to varied environmental conditions. Recent trends also showcase rising public acceptance of transgenic animals, especially those that contribute to medical research and pharmaceutical production. The US government has reinforced this trend by facilitating partnerships between public and private sectors to accelerate the development and commercialization of transgenic products.

Another notable trend is the growing investment in precision breeding technologies, which further enhances the ability to create animals with desired traits. The focus on sustainable and ethical practices in animal farming continues to shape consumer preferences, driving the market towards responsible innovations. Overall, the US Transgenic Animals Market is evolving with a strong emphasis on research and regulatory facilitation, creating a dynamic ecosystem for growth.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Transgenic Animals Market Drivers

Advancements in Genetic Engineering Techniques

The US Transgenic Animals Market Industry is experiencing robust growth due to continuous advancements in genetic engineering techniques. Recent innovations in CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology have made it significantly easier and more cost-effective to create transgenic animals, particularly in the biomedical field. According to the National Institute of Health, over the past decade, research funding for genetic engineering has increased by approximately 25%, reflecting the growing interest and potential in this field.

Institutions like Stanford University and MIT are at the forefront, driving Research and Development (R&D) efforts that emphasize the creation of transgenic animals for enhanced disease resistance in livestock and improvement of pharmaceutical production. These advancements are expected to enhance production efficiency and are leading to an expected market expansion, as stakeholders look for innovative solutions to meet food security and public health challenges.

Rising Demand for Organ Transplants

Another significant driver for the US Transgenic Animals Market Industry is the increasing demand for organ transplants. As reported by the United States Department of Health and Human Services, there were over 39,000 organ transplants in the US in 2022 alone, highlighting a 3.5% annual increase in transplant procedures. This growing demand is prompting researchers to explore transgenic animals as potential organ donors. Institutions such as Harvard Medical School have initiated projects involving genetically modified pigs with organs that are more compatible for human transplantation.

The need to alleviate the shortage of available organs is becoming more urgent, thereby propelling market growth for transgenic animal solutions that can provide viable alternatives.

Supportive Government Regulations

The US Transgenic Animals Market Industry is being positively impacted by supportive government regulations that encourage the development and commercialization of transgenic animals. The United States Department of Agriculture (USDA) has made strides in streamlining the regulatory process for genetically modified organisms, allowing for faster approvals and fostering innovation. Recent guidelines published by the USDA indicate the agency's intent to promote biotechnology applications in agriculture.

This regulatory atmosphere is essential for enhancing investment confidence, encouraging private sector participation while providing a framework that ensures safety and efficacy. Such measures are crucial for maintaining public trust and driving forward the adoption of transgenic technologies in agriculture and medicine.

US Transgenic Animals Market Segment Insights

Transgenic Animals Market Products Insights

The Products segment of the US Transgenic Animals Market has emerged as a pivotal area contributing to the advancement of genetic engineering and biotechnology. With applications across various industries including pharmaceuticals, agriculture, and Research and Development (R&D), this market segment plays a vital role in addressing pressing global challenges. Among the various tools utilized for genetic modification, techniques such as Gene Gun and Microinjection stand out due to their specific advantages in the transformation processes of animals.

Gene Gun technology enables the delivery of genetic material into target cells using high-velocity micro-projectiles, facilitating the precise modification of animal genomes. This method is particularly valued for its efficiency and effectiveness in gene transfer, leading to significant enhancements in livestock production traits, disease resistance, and overall animal health. Furthermore, the method is instrumental in generating transgenic models for human disease research, thereby bridging the gap between animal husbandry and biomedical studies.

On the other hand, Microinjection remains a leading technique for introducing foreign DNA directly into fertilized eggs, creating high-quality transgenic animals capable of expressing desired traits. This technology is prominent for its precision and high success rate, allowing researchers to achieve specific genetic alterations that can be inherited in subsequent generations. The significance of Microinjection lies not only in its contributions to the agricultural sector, where it aids in developing transgenic animals with improved performance and sustainability, but also in its role within the biomedical field, promoting advances in disease modeling and therapeutics.

As part of the broader US Transgenic Animals Market landscape, these specifically tailored products provide numerous opportunities for innovation and improvement. The growth of this sector is driven by increasing quests for sustainable agricultural practices and advancements in genetic technology, thus supporting the development of transgenic animals that not only enhance food production efficiency but also contribute to environmental sustainability. While challenges such as regulatory hurdles and public acceptance remain, the potential benefits of these products reinforce their significance within the industry and highlight the importance of continuing research and development efforts in the field.

The ongoing evolution of the US Transgenic Animals Market is indicative of a growing recognition of the transformative powers of genetic technologies, paving the way for a future where transgenic animals play an integral role in meeting both economic and societal needs.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Transgenic Animals Market Key Players and Competitive Insights

The US Transgenic Animals Market is characterized by a dynamic landscape where innovation and technological advancements play pivotal roles in shaping competitive strategies among key players. This market thrives on the potential of genetically modified animals, which hold promises for various applications such as agriculture, pharmaceuticals, and biomedical advancements. The competitive environment is influenced by factors such as regulatory frameworks, consumer acceptance, and the continuous evolution of genetic engineering technologies. Companies in this market are engaged in extensive research and development to create novel transgenic models that can enhance productivity in livestock, improve disease resistance, and develop biopharmaceuticals, which drives the competition and differentiation among them.

As scientific knowledge progresses, firms are leveraging intellectual property to secure their innovations while also navigating ethical considerations that influence market growth and player strategies. Genus has established a strong presence in the US Transgenic Animals Market through its commitment to providing advanced animal genetics aimed at enhancing livestock productivity. One of the key strengths of Genus lies in its robust research and development capabilities, which enable the company to deliver high-quality genetic solutions in swine and cattle. The company has a substantial foothold in the market driven by its innovative breeding techniques and successful commercialization of genetically engineered traits that optimize performance and sustainability in agricultural practices.

Genus’s strategic partnerships with research institutions and a focus on improving animal health and welfare further enhance its competitive advantage, solidifying its reputation as a leader in transgenic animal development for various agricultural applications. Hughson Ag distinguishes itself within the US Transgenic Animals Market by focusing on pioneering genetic solutions tailored for improved agricultural productivity. The company markets a diverse portfolio of transgenic animal products including genetically modified livestock designed to enhance disease resistance and yield efficiency. Hughson Ag's strengths include its innovative approach to genetic engineering, which is supported by a dedicated team of scientists and researchers focused on advancing genetic technologies.

The company has expanded its market presence through strategic mergers and acquisitions aimed at augmenting its R&D capabilities and diversifying its product offerings. By investing in cutting-edge technologies and establishing collaborations with leading research institutions, Hughson Ag continues to position itself as a competitive force in the transgenic animals sector, ultimately aiming to deliver solutions that meet the evolving demands of the US agriculture market.

Key Companies in the US Transgenic Animals Market Include

• Genus


• Hughson Ag


• InVivo Therapeutics


• Livestock Genetic Innovations


• Horizon Discovery


• ViaGen Pets


• Syngenta


• Recombinetics


• Transylvania Biotechnology


• AquaBounty Technologies


• Addgene


• Maryland Biotechnology Institute

US Transgenic Animals Market Industry Developments

In the US Transgenic Animals Market, significant developments are shaping the landscape. Notably, AquaBounty Technologies has made strides with its genetically modified salmon, enhancing growth efficiency and addressing food security concerns. Additionally, companies like Genus and Livestock Genetic Innovations are increasingly focused on enhancing livestock productivity and disease resistance through genetic advancements. Recent merger and acquisition activities in this sector include an acquisition by Recombinetics, which expanded its portfolio by acquiring a gene-editing technology firm in March 2023, while ViaGen Pets reported collaboration with Maryland Biotechnology Institute in February 2023 to advance the use of transgenic techniques in pet cloning.

The market has also seen a valuation growth in companies like Horizon Discovery, benefiting from the rising demand for genetic solutions in agriculture and environmental sustainability. The ongoing advancements and regulatory attention toward transgenic technologies in the US are leading to more investments and collaboration among these firms, fostering innovation and responding to consumer demands for sustainable practices. Major happenings over the last couple of years, including Syngenta’s partnerships in biotechnology in June 2021, have further catalyzed growth opportunities within the market, reflecting the dynamic nature of this evolving industry.

US Transgenic Animals Market Segmentation Insights

Transgenic Animals Market Products Outlook

• Gene Gun


• Microinjection

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	0.88(USD Billion)
MARKET SIZE 2024	1.08(USD Billion)
MARKET SIZE 2035	3.14(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	10.189% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Genus, Hughson Ag, InVivo Therapeutics, Livestock Genetic Innovations, Horizon Discovery, ViaGen Pets, Syngenta, Recombinetics, Transylvania Biotechnology, AquaBounty Technologies, Addgene, Maryland Biotechnology Institute
SEGMENTS COVERED	Products
KEY MARKET OPPORTUNITIES	Growing demand for personalized medicine, Advancements in gene-editing technologies, Increased agricultural efficiency, Rising interest in sustainable farming, Development of innovative biopharmaceuticals
KEY MARKET DYNAMICS	Regulatory challenges, Technological advancements, Ethical considerations, Consumer acceptance, Research funding availability
COUNTRIES COVERED	US